Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission.
[hodgkin lymphoma, classical]
The
objective
of
this
study
was
to
compare
the
outcomes
of
patients
with
classical
Hodgkin
lymphoma
(
cHL
)
who
achieved
complete
remission
with
frontline
therapy
and
then
underwent
either
clinical
surveillance
or
routine
surveillance
imaging
.
In
total
,
241
patients
who
were
newly
diagnosed
with
cHL
between
January
2000
and
December
2010
at
3
participating
tertiary
care
centers
and
achieved
complete
remission
after
first
-line
therapy
were
retrospectively
analyzed
.
Of
these
,
there
were
174
patients
in
the
routine
surveillance
imaging
group
and
67
patients
in
the
clinical
surveillance
group
,
based
on
the
intended
mode
of
surveillance
.
In
the
routine
surveillance
imaging
group
,
the
intended
plan
of
surveillance
included
computed
tomography
and
/
or
positron
emission
tomography
scans
;
whereas
,
in
the
clinical
surveillance
group
,
the
intended
plan
of
surveillance
was
clinical
examination
and
laboratory
studies
,
and
scans
were
obtained
only
to
evaluate
concerning
signs
or
symptoms
.
Baseline
patient
characteristics
,
prognostic
features
,
treatment
records
,
and
outcomes
were
collected
.
The
primary
objective
was
to
compare
overall
survival
for
patients
in
both
groups
.
For
secondary
objectives
,
we
compared
the
success
of
second
-line
therapy
and
estimated
the
costs
of
imaging
for
each
group
.
After
5
years
of
follow-up
,
the
overall
survival
rate
was
97
%
(
95
%
confidence
interval
,
92
%
-
99
%
)
in
the
routine
surveillance
imaging
group
and
96
%
(
95
%
confidence
interval
,
87
%
-
99
%
)
in
the
clinical
surveillance
group
(
P
=
.
41
)
.
There
were
few
relapses
in
each
group
,
and
all
patients
who
relapsed
in
both
groups
achieved
complete
remission
with
second
-line
therapy
.
The
charges
associated
with
routine
surveillance
imaging
were
significantly
higher
than
those
for
the
clinical
surveillance
strategy
,
with
no
apparent
clinical
benefit
.
Clinical
surveillance
was
not
inferior
to
routine
surveillance
imaging
in
patients
with
cHL
who
achieved
complete
remission
with
frontline
therapy
.
Routine
surveillance
imaging
was
associated
with
significantly
increased
estimated
imaging
charges
.
Diseases
Validation
Diseases presenting
"routine surveillance imaging were significantly higher than those for the clinical surveillance strategy"
symptom
hodgkin lymphoma, classical
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom